Net Income for DexCom (DXCM)
According to DexCom's latest reported financial statements, the company's current net income (TTM) is $836.30M USD. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
DXCM
Currently viewingNet IncomeSwitch metric
TTM (last 4 quarters)
$836.30M
YoY change
+45.1%
5Y CAGR
+11.1%
Peak year (2025)
$836.30M
Cumulative net income
$2.33B
Net Income history chart for DexCom (DXCM) from 2000 to 2025
Net Income history table for DexCom (DXCM) from 2000 to 2025
| Fiscal year | Period ended | Reported | Net Income | YoY |
|---|---|---|---|---|
| 2025 | $836.30M | +45.1% | ||
| 2024 | $576.20M | +6.4% | ||
| 2023 | $541.50M | +58.7% | ||
| 2022 | $341.20M | +57.3% | ||
| 2021 | $216.90M | -56.1% | ||
| 2020 | $493.60M | +388.2% | ||
| 2019 | $101.10M | -179.5% | ||
| 2018 | -$127.10M | +153.2% | ||
| 2017 | -$50.20M | -23.5% | ||
| 2016 | -$65.60M | +13.9% | ||
| 2015 | -$57.60M | +157.1% | ||
| 2014 | -$22.40M | -24.8% | ||
| 2013 | -$29.80M | -45.3% | ||
| 2012 | -$54.50M | +21.8% | ||
| 2011 | -$44.75M | -18.9% | ||
| 2010 | -$55.17M | +3.1% | ||
| 2009 | -$53.52M | -3.0% | ||
| 2008 | -$55.18M | +20.3% | ||
| 2007 | -$45.88M | -1.5% | ||
| 2006 | -$46.60M | +51.5% | ||
| 2005 | -$30.77M | +120.6% | ||
| 2004 | -$13.95M | +40.7% | ||
| 2003 | -$9.91M | +28.6% | ||
| 2002 | -$7.71M | +22.9% | ||
| 2001 | -$6.27M | +58.2% | ||
| 2000 | -$3.96M | — |
Net Income values are taken from DexCom's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, DexCom (DXCM) net income totalled $836.30M – surged 45.1% year-over-year.
DexCom net income compound annual growth for the 2020–2025 (5 years) window is +11.1%, sustaining 4 straight years of year-over-year growth.
The dataset's maximum net income sits at $836.30M (2025); the minimum reading of -$127.10M dates to 2018.
DexCom (DXCM) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $15.15B.
DexCom Net Income by Year
DexCom Net Income 2025: $836.30M
DexCom net income in 2025 was $836.30M, surged 45.1% from 2024. This figure represents the highest annual value in the available history.
DexCom Net Income 2024: $576.20M
DexCom net income in 2024 was $576.20M, grew 6.4% from 2023.
DexCom Net Income 2023: $541.50M
DexCom net income in 2023 was $541.50M, surged 58.7% from 2022.
DexCom Net Income 2022: $341.20M
DexCom net income in 2022 was $341.20M, surged 57.3% from 2021.
DexCom Net Income 2021: $216.90M
DexCom net income in 2021 was $216.90M.
See more financial history for DexCom (DXCM).
Sector peers — Net Income
Companies in the same sector as DexCom, ranked by their latest net income.
| Company | Net Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $102.43B | Healthcare |
| Johnson & Johnson (JNJ) | $26.80B | Healthcare |
| Eli Lilly and Company (LLY) | $20.64B | Healthcare |
| Merck & Co., Inc. (MRK) | $18.25B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $12.06B | Healthcare |
| AstraZeneca PLC (AZN) | $10.26B | Healthcare |
| Amgen Inc. (AMGN) | $7.71B | Healthcare |
| AbbVie Inc. (ABBV) | $4.23B | Healthcare |
Frequently asked questions
What is DexCom's net income?
- Latest reported net income for DexCom (DXCM) is $836.30M (period ending December 31, 2025).
How has DexCom net income changed year-over-year?
- DexCom (DXCM) net income changed +45.1% year-over-year on the latest annual filing.
What is the long-term growth rate of DexCom net income?
- DexCom (DXCM) net income compound annual growth rate is +11.1% over the most recent 5 years available.
When did DexCom net income hit its highest annual value?
- DexCom net income reached its highest annual value of $836.30M in 2025.
What was DexCom net income in 2024?
- DexCom (DXCM) net income in 2024 was $576.20M.
What was DexCom net income in 2025?
- DexCom (DXCM) net income in 2025 was $836.30M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DXCM Overview
Company profile, financial tools, and key metrics
DXCM Revenue Counter
Earns $147.83 every second. See per minute, hour, and day.
DXCM Earnings Counter
Earns $26.52 per second net profit. See per minute, hour, and day.
DXCM Economic Scale
Exceeds Suriname's GDP. Compare with world economies.
DXCM What If Invested
What if you had invested $1,000? See historical returns from any date.
DXCM How It Makes Money
Discover visual breakdown of $4.66B in revenue — where it comes from and where it goes.
DXCM Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DXCM Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DXCM Daily Price Character
Explosive · 49.4% historical win rate (green days). Streaks & record days.
DXCM Buybacks
1.95% TTM buyback yield. Shareholder yield & SBC comparison.
DXCM Stock Split History
1 split on record. Dates, ratios, and cumulative multiple.